Similar articles for PMID: 34732427

Year	Number of Results
1887	1
2008	1
2009	1
2011	1
2012	4
2013	8
2014	12
2015	8
2016	8
2017	20
2018	20
2019	25
2020	35
2021	39
2022	45
2023	29
2024	31

1

Peritoneal Spread of Low-grade Appendiceal Tumours - 2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough.

Rao A, Mui J, Barat S, Matar AA, Alzahrani N, Morris DL. Rao A, et al. Anticancer Res. 2021 Nov;41(11):5569-5575. doi: 10.21873/anticanres.15370. Anticancer Res. 2021. PMID: 34732427

2

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysis.

Soucisse ML, Fisher O, Liauw W, Ghanipour L, Cashin P. Soucisse ML, et al. Eur J Surg Oncol. 2021 Jan;47(1):157-163. doi: 10.1016/j.ejso.2020.08.026. Epub 2020 Sep 6. Eur J Surg Oncol. 2021. PMID: 32943277

3

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.

Di Leo A, Corvasce A, Weindelmayer J, Mason EJ, Casella F, de Manzoni G. Di Leo A, et al. Updates Surg. 2020 Dec;72(4):1207-1212. doi: 10.1007/s13304-020-00788-5. Epub 2020 May 14. Updates Surg. 2020. PMID: 32410159

4

Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei.

Liu Q, Jiao J, Li C, Chen Y, Wang B, Shi J, Yu G. Liu Q, et al. World J Surg Oncol. 2024 May 21;22(1):134. doi: 10.1186/s12957-024-03412-7. World J Surg Oncol. 2024. PMID: 38769546 Free PMC article.

5

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, Goere D, Baratti D, Nizri E, Morris DL, Glehen O, Sardi A, Barrios P, Quénet F, Villeneuve L, Gómez-Portilla A, de Hingh I, Ceelen W, Pelz JOW, Piso P, González-Moreno S, Van Der Speeten K, Deraco M; Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE). Kusamura S, et al. JAMA Surg. 2021 Mar 1;156(3):e206363. doi: 10.1001/jamasurg.2020.6363. Epub 2021 Mar 10. JAMA Surg. 2021. PMID: 33502455 Free PMC article.

6

Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.

Ward EP, Okamuro L, Khan S, Hosseini M, Valasek MA, Ronquillo N Jr, Kelly KJ, Veerapong J, Lowy AM, Baumgartner J. Ward EP, et al. Hum Pathol. 2021 Jul;113:104-110. doi: 10.1016/j.humpath.2021.04.007. Epub 2021 Apr 24. Hum Pathol. 2021. PMID: 33905776

7

Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.

Lam JY, McConnell YJ, Rivard JD, Temple WJ, Mack LA. Lam JY, et al. Am J Surg. 2015 Sep;210(3):424-30. doi: 10.1016/j.amjsurg.2015.03.008. Epub 2015 May 12. Am J Surg. 2015. PMID: 26051744

8

Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.

Sutton PA, O'Dwyer ST, Barriuso J, Aziz O, Selvasekar CR, Renehan AG, Wilson MS. Sutton PA, et al. Surg Oncol. 2021 Sep;38:101572. doi: 10.1016/j.suronc.2021.101572. Epub 2021 Apr 20. Surg Oncol. 2021. PMID: 33915487

9

Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.

Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L. Marcotte E, et al. World J Surg Oncol. 2014 Nov 7;12:332. doi: 10.1186/1477-7819-12-332. World J Surg Oncol. 2014. PMID: 25380618 Free PMC article.

10

Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?

Huang Y, Alzahrani NA, Liauw W, Traiki TB, Morris DL. Huang Y, et al. Ann Surg Oncol. 2017 Jan;24(1):176-183. doi: 10.1245/s10434-016-5529-0. Epub 2016 Oct 7. Ann Surg Oncol. 2017. PMID: 27718032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34732427

232 results

Results by year